These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8345163)

  • 21. Atenolol treatment of late luteal phase dysphoric disorder.
    Rausch JL; Janowsky DS; Golshan S; Kuhn K; Risch SC
    J Affect Disord; 1988; 15(2):141-7. PubMed ID: 2975684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of metergoline on symptoms in women with premenstrual dysphoric disorder.
    Roca CA; Schmidt PJ; Smith MJ; Danaceau MA; Murphy DL; Rubinow DR
    Am J Psychiatry; 2002 Nov; 159(11):1876-81. PubMed ID: 12411222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Premenstrual dysphoric disorder in an adolescent female.
    Nur MM; Romano ME; Siqueira LM
    J Pediatr Adolesc Gynecol; 2007 Jun; 20(3):201-4. PubMed ID: 17561191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does Adding Fluoxetine to Combined Oral Contraceptives Containing Drospirenone Improve the Management of Severe Premenstrual Syndrome? A 6-Month Randomized Double-Blind Placebo-Controlled Three-Arm Trial.
    Shehata NAA; Moety GAFA; El Wahed HAA; Fahim AS; Katta MA; Hussein GK
    Reprod Sci; 2020 Feb; 27(2):743-750. PubMed ID: 32046452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind trial of four medications to treat severe premenstrual syndrome.
    Diegoli MS; da Fonseca AM; Diegoli CA; Pinotti JA
    Int J Gynaecol Obstet; 1998 Jul; 62(1):63-7. PubMed ID: 9722128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomized, double-blind, placebo-controlled crossover trial.
    Young SA; Hurt PH; Benedek DM; Howard RS
    J Clin Psychiatry; 1998 Feb; 59(2):76-80. PubMed ID: 9501889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Premenstrual dysphoric disorder in adolescents: case reports of treatment with fluoxetine and review of the literature.
    Silber TJ; Valadez-Meltzer A
    J Adolesc Health; 2005 Dec; 37(6):518-25. PubMed ID: 16310133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder.
    Halbreich U; Bergeron R; Yonkers KA; Freeman E; Stout AL; Cohen L
    Obstet Gynecol; 2002 Dec; 100(6):1219-29. PubMed ID: 12468166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrence of symptoms of premenstrual dysphoric disorder after the cessation of luteal-phase fluoxetine treatment.
    Pearlstein T; Joliat MJ; Brown EB; Miner CM
    Am J Obstet Gynecol; 2003 Apr; 188(4):887-95. PubMed ID: 12712081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy of fluoxetine in improving physical symptoms associated with premenstrual dysphoric disorder.
    Steiner M; Romano SJ; Babcock S; Dillon J; Shuler C; Berger C; Carter D; Reid R; Stewart D; Steinberg S; Judge R
    BJOG; 2001 May; 108(5):462-8. PubMed ID: 11368130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind comparison of fluoxetine, imipramine and placebo in outpatients with major depression.
    Feighner JP; Boyer WF; Merideth CH; Hendrickson GG
    Int Clin Psychopharmacol; 1989 Apr; 4(2):127-34. PubMed ID: 2663975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gonadotropin-releasing hormone agonist in treatment of premenstrual symptoms with and without comorbidity of depression: a pilot study.
    Freeman EW; Sondheimer SJ; Rickels K; Albert J
    J Clin Psychiatry; 1993 May; 54(5):192-5. PubMed ID: 8509350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alprazolam in the treatment of premenstrual syndrome. A double-blind, placebo-controlled trial.
    Schmidt PJ; Grover GN; Rubinow DR
    Arch Gen Psychiatry; 1993 Jun; 50(6):467-73. PubMed ID: 8498881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A preliminary study of luteal phase versus symptom-onset dosing with escitalopram for premenstrual dysphoric disorder.
    Freeman EW; Sondheimer SJ; Sammel MD; Ferdousi T; Lin H
    J Clin Psychiatry; 2005 Jun; 66(6):769-73. PubMed ID: 15960573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase.
    Yonkers KA; Pearlstein T; Fayyad R; Gillespie JA
    J Affect Disord; 2005 Apr; 85(3):317-21. PubMed ID: 15780701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome.
    Freeman EW; Rickels K; Sondheimer SJ; Polansky M
    JAMA; 1995 Jul; 274(1):51-7. PubMed ID: 7791258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double-blind randomized crossover trial of luteal phase estrogens (Premarin) in the premenstrual syndrome (PMS).
    Dhar V; Murphy BE
    Psychoneuroendocrinology; 1990; 15(5-6):489-93. PubMed ID: 1966304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial.
    Sundblad C; Hedberg MA; Eriksson E
    Neuropsychopharmacology; 1993 Sep; 9(2):133-45. PubMed ID: 8216696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive.
    Graham CA; Sherwin BB
    J Psychosom Res; 1992 Apr; 36(3):257-66. PubMed ID: 1564678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of curcumin on serum brain-derived neurotrophic factor levels in women with premenstrual syndrome: A randomized, double-blind, placebo-controlled trial.
    Fanaei H; Khayat S; Kasaeian A; Javadimehr M
    Neuropeptides; 2016 Apr; 56():25-31. PubMed ID: 26608718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.